Schmidt, K.G.; Harrer, E.G.; Tascilar, K.; Kübel, S.; El Kenz, B.; Hartmann, F.; Simon, D.; Schett, G.; Nganou-Makamdop, K.; Harrer, T.
Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection. Viruses 2022, 14, 651.
https://doi.org/10.3390/v14030651
AMA Style
Schmidt KG, Harrer EG, Tascilar K, Kübel S, El Kenz B, Hartmann F, Simon D, Schett G, Nganou-Makamdop K, Harrer T.
Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection. Viruses. 2022; 14(3):651.
https://doi.org/10.3390/v14030651
Chicago/Turabian Style
Schmidt, Katja G., Ellen G. Harrer, Koray Tascilar, Sabrina Kübel, Boutaina El Kenz, Fabian Hartmann, David Simon, Georg Schett, Krystelle Nganou-Makamdop, and Thomas Harrer.
2022. "Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection" Viruses 14, no. 3: 651.
https://doi.org/10.3390/v14030651
APA Style
Schmidt, K. G., Harrer, E. G., Tascilar, K., Kübel, S., El Kenz, B., Hartmann, F., Simon, D., Schett, G., Nganou-Makamdop, K., & Harrer, T.
(2022). Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection. Viruses, 14(3), 651.
https://doi.org/10.3390/v14030651
